Hailun Li

2.3k total citations
45 papers, 1.6k citations indexed

About

Hailun Li is a scholar working on Pathology and Forensic Medicine, Oncology and Epidemiology. According to data from OpenAlex, Hailun Li has authored 45 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 14 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Hailun Li's work include Lymphoma Diagnosis and Treatment (17 papers), Viral-associated cancers and disorders (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Hailun Li is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), Viral-associated cancers and disorders (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Hailun Li collaborates with scholars based in United States, China and Canada. Hailun Li's co-authors include Rebecca Gelman, So Yeon Park, Kornélia Polyák, Michail Shipitsin, Hee Eun Lee, Qingping Xiong, Brad S. Kahl, Randy D. Gascoyne, Sandra J. Horning and Ranjana H. Advani and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Hailun Li

42 papers receiving 1.6k citations

Peers

Hailun Li
Jihye Yun United States
Hua You China
Li Wu China
Yuhua Li China
Ming Tat Ling Hong Kong
Jihye Yun United States
Hailun Li
Citations per year, relative to Hailun Li Hailun Li (= 1×) peers Jihye Yun

Countries citing papers authored by Hailun Li

Since Specialization
Citations

This map shows the geographic impact of Hailun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hailun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hailun Li more than expected).

Fields of papers citing papers by Hailun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hailun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hailun Li. The network helps show where Hailun Li may publish in the future.

Co-authorship network of co-authors of Hailun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hailun Li. A scholar is included among the top collaborators of Hailun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hailun Li. Hailun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Haiming, Bin Tang, Xiaoyu Ma, et al.. (2025). Modulation of the gut-skin axis by polysaccharides: Mechanisms and therapeutic potential in immune-related skin diseases. Carbohydrate Polymers. 369. 124143–124143.
2.
Kong, Jianping, et al.. (2025). The relationship between cardiometabolic Index and diabetic kidney disease in people with diabetes. Frontiers in Endocrinology. 15. 1376813–1376813.
3.
Wang, Weiqi, Hailun Li, Hongli Jin, et al.. (2024). Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2. Antiviral Research. 227. 105905–105905. 1 indexed citations
4.
Rosain, Jérémie, Ayça Kıykım, Yasemin Kendir Demirkol, et al.. (2024). Recombinant IFN-γ1b Treatment in a Patient with Inherited IFN-γ Deficiency. Journal of Clinical Immunology. 44(3). 62–62. 1 indexed citations
6.
Li, Hailun, Xinxin Yu, Jing Li, et al.. (2024). Sijunzi decoction alleviates inflammation and intestinal epithelial barrier damage and modulates the gut microbiota in ulcerative colitis mice. Frontiers in Pharmacology. 15. 1360972–1360972. 17 indexed citations
7.
Cheng, Yajun, Xiaolong Wang, Xi Wang, et al.. (2024). Chinese herbal decoction, Yi-Qi-Jian-Pi formula exerts anti-hepatic fibrosis effects in mouse models of CCl4-induced liver fibrosis. Heliyon. 10(5). e26129–e26129. 6 indexed citations
8.
Li, Hailun, Can Peng, Jingrui Ma, et al.. (2023). Application of protein/polysaccharide aerogels in drug delivery system: A review. International Journal of Biological Macromolecules. 247. 125727–125727. 40 indexed citations
9.
Gong, Zhiyuan, Pei Huang, Hongli Jin, et al.. (2023). A recombinant rabies virus chimera expressing the DC-targeting molecular MAB2560 shows enhanced vaccine immunogenicity through activation of dendritic cells. PLoS neglected tropical diseases. 17(4). e0011254–e0011254. 2 indexed citations
10.
Li, Hailun, Yifan Wen, Qingping Xiong, et al.. (2021). Tremella fuciformis polysaccharides ameliorated ulcerative colitis via inhibiting inflammation and enhancing intestinal epithelial barrier function. International Journal of Biological Macromolecules. 180. 633–642. 79 indexed citations
11.
Yuan, Jun, Hailun Li, Qian Han, et al.. (2020). An effective method for extracting anthocyanins from blueberry based on freeze-ultrasonic thawing technology. Ultrasonics Sonochemistry. 68. 105192–105192. 33 indexed citations
12.
Xiong, Qingping, Jian Liang, Jun Yuan, et al.. (2020). Polydatin alleviates high-fat diet induced atherosclerosis in apolipoprotein E-deficient mice by autophagic restoration. Phytomedicine. 81. 153301–153301. 17 indexed citations
13.
Greenwald, Daniel, Hailun Li, Selina M. Luger, et al.. (2013). A phase II study of sorafenib (BAY 43–9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404). Journal of Hematology & Oncology. 6(1). 46–46. 10 indexed citations
15.
Lu, Weidong, Peter M. Wayne, Roger B. Davis, et al.. (2012). Acupuncture for dysphagia after chemoradiation in head and neck cancer: Rationale and design of a randomized, sham-controlled trial. Contemporary Clinical Trials. 33(4). 700–711. 21 indexed citations
16.
Park, So Yeon, Hee Eun Lee, Hailun Li, et al.. (2010). Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer. Clinical Cancer Research. 16(3). 876–887. 325 indexed citations
17.
Miron, Alexander, Mária Váradi, Daniel R. Carrasco, et al.. (2010). PIK3CA Mutations in In situ and Invasive Breast Carcinomas. Cancer Research. 70(14). 5674–5678. 107 indexed citations
18.
Dreicer, Robert, Hailun Li, Mark N. Stein, et al.. (2009). Phase 2 trial of sorafenib in patients with advanced urothelial cancer. Cancer. 115(18). 4090–4095. 108 indexed citations
19.
Li, Hailun, et al.. (2009). The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer. Cancer. 115(14). 3189–3195. 68 indexed citations
20.
Dreicer, Robert, Hailun Li, Matthew M. Cooney, George Wilding, & Bruce J. Roth. (2008). Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802). Cancer. 112(12). 2671–2675. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026